Live Breaking News & Updates on கோதீ பல்கலைக்கழகம் மருத்துவமனை

Stay updated with breaking news from கோதீ பல்கலைக்கழகம் மருத்துவமனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics Announces Changes to Management


DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics Announces Changes to Management
Atriva Therapeutics Announces Changes to Management
13.04.2021 / 09:30
Atriva Therapeutics Announces Changes to Management
- Olaf Althaus appointed Chief Financial Officer
- Stephan Stenglein, M.D., recently joined as Chief Medical Officer
- Proven track record and 20+ years of experience in their respective fields of expertise
Tübingen (Germany), April 13, 2021 - Atriva Therapeutics GmbH, a biopharmaceutical company that is pioneering the development of host-targeting antiviral therapies, today announced two changes to its management team. Olaf Althaus was appointed Chief Financial Officer, effective May 2020, while Stephan Stenglein, M.D., was named Chief Medical Officer, effective February 2021. ....

Frankfurt Am Main , Nordrhein Westfalen , City Of , United Kingdom , Eva Bauer Raimund Gabriel , Olaf Althaus , Stephan Stenglein , Kostenloser Wertpapierhandel , Gernot Rohde , Aeterna Zentaris Gmb , Rainer Lichtenberger , Mc Services , Global Program , Global Program Clinical Head , Centre Clinical Trial To Evaluate The Safety , Distribution Services , Stage Development Respiratory At Astrazeneca , Shire Plc , Goethe University Hospital , Karlsruhe University Diplom Wirtschaftsingenieurwesen , Vp Clinical Sciences At Glenmark Pharmaceuticals , Atriva Therapeutics Gmbh , Therapeutics Announces Changes , Chief Financial , Chief Medical , Therapeutics Gmbh ,

Versantis Announces Positive Phase 1b Results for VS-01 in Patients with Decompensated Cirrhosis


Versantis Announces Positive Phase 1b Results for VS-01 in Patients with Decompensated Cirrhosis
Promising data supports advancing VS-01 into Phase 2a POC study in Acute on Chronic Liver Failure
Versantis, a clinical-stage company developing novel therapies for orphan liver and pediatric diseases, today announced positive results from a Phase 1b clinical trial of VS-01 in decompensated liver cirrhosis. VS-01 was found to be safe and well tolerated in this first-in-human, single ascending and multiple dose study led by Prof. Dr. Jonel Trebicka at the Goethe University Hospital Frankfurt. VS-01 is a potentially lifesaving, multi-organ support therapy that aims to reverse Acute-on-Chronic Liver Failure (ACLF) by enhancing the clearance of ammonia and other toxins from the body. ....

Kostenloser Wertpapierhandel , Meriam Kabbaj , Vincent Foster , Jonel Trebicka , Vincent Forster , Lorenz Pabijan , Mike Sinclair , Goethe University Hospital Frankfurt , Chronic Liver Failure , Goethe University Hospital , Acute On Chronic Liver Failure , Prof Trebicka , Mrs Graf Dirmeier , Mrs Lorenz Pabijan , Rare Pediatric Diseases Designation , வின்சென்ட் வளர்ப்பு , வின்சென்ட் ஃபார்ஸ்டர் , மைக் சின்க்ளேர் , கோதீ பல்கலைக்கழகம் மருத்துவமனை பிராங்க்ஃபர்ட் , நாள்பட்ட கல்லீரல் தோல்வி , கோதீ பல்கலைக்கழகம் மருத்துவமனை , எடுப்போசை ஆன் நாள்பட்ட கல்லீரல் தோல்வி , ரேர் குழந்தை நோய்கள் பதவி ,